Cargando…

Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV Populations

High-resolution flow cytometers (hFCM) are used for the detection of extracellular vesicles (EV) in various biological fluids. Due to the increased sensitivity of hFCM, new artifacts with the potential of interfering with data interpretation are introduced, such as detection of antibody aggregates....

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Rikke W., Botha, Jaco, Prip, Frederik, Sanden, Mathilde, Nielsen, Morten H., Handberg, Aase
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923005/
https://www.ncbi.nlm.nih.gov/pubmed/33670624
http://dx.doi.org/10.3390/biomedicines9020206
_version_ 1783658817008959488
author Rasmussen, Rikke W.
Botha, Jaco
Prip, Frederik
Sanden, Mathilde
Nielsen, Morten H.
Handberg, Aase
author_facet Rasmussen, Rikke W.
Botha, Jaco
Prip, Frederik
Sanden, Mathilde
Nielsen, Morten H.
Handberg, Aase
author_sort Rasmussen, Rikke W.
collection PubMed
description High-resolution flow cytometers (hFCM) are used for the detection of extracellular vesicles (EV) in various biological fluids. Due to the increased sensitivity of hFCM, new artifacts with the potential of interfering with data interpretation are introduced, such as detection of antibody aggregates. The aim of this study was to investigate the extent of aggregates in labels commonly used for the characterization of EVs by hFCM. Furthermore, we aimed to compare the efficacy of centrifugation and filtering treatments to remove aggregates, as well as to quantify the effect of the treatments in reducing aggregates. For this purpose, we labeled phosphate buffered saline (PBS) with fluorescently conjugated protein labels and antibodies after submitting them to 5, 10, or 30 min centrifugation, filtering or washed filtering. We investigated samples by hFCM and quantified the amount of aggregates found in PBS labeled with untreated and pre-treated labels. We found a varying amount of aggregates in all labels investigated, and further that filtering is most efficient in removing all but the smallest aggregates. Filtering protein labels can reduce the extent of aggregates; however, how much remains depends on the specific labels and their combination. Therefore, it is still necessary to include appropriate controls in a hFCM study of EVs.
format Online
Article
Text
id pubmed-7923005
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79230052021-03-03 Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV Populations Rasmussen, Rikke W. Botha, Jaco Prip, Frederik Sanden, Mathilde Nielsen, Morten H. Handberg, Aase Biomedicines Article High-resolution flow cytometers (hFCM) are used for the detection of extracellular vesicles (EV) in various biological fluids. Due to the increased sensitivity of hFCM, new artifacts with the potential of interfering with data interpretation are introduced, such as detection of antibody aggregates. The aim of this study was to investigate the extent of aggregates in labels commonly used for the characterization of EVs by hFCM. Furthermore, we aimed to compare the efficacy of centrifugation and filtering treatments to remove aggregates, as well as to quantify the effect of the treatments in reducing aggregates. For this purpose, we labeled phosphate buffered saline (PBS) with fluorescently conjugated protein labels and antibodies after submitting them to 5, 10, or 30 min centrifugation, filtering or washed filtering. We investigated samples by hFCM and quantified the amount of aggregates found in PBS labeled with untreated and pre-treated labels. We found a varying amount of aggregates in all labels investigated, and further that filtering is most efficient in removing all but the smallest aggregates. Filtering protein labels can reduce the extent of aggregates; however, how much remains depends on the specific labels and their combination. Therefore, it is still necessary to include appropriate controls in a hFCM study of EVs. MDPI 2021-02-18 /pmc/articles/PMC7923005/ /pubmed/33670624 http://dx.doi.org/10.3390/biomedicines9020206 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rasmussen, Rikke W.
Botha, Jaco
Prip, Frederik
Sanden, Mathilde
Nielsen, Morten H.
Handberg, Aase
Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV Populations
title Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV Populations
title_full Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV Populations
title_fullStr Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV Populations
title_full_unstemmed Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV Populations
title_short Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV Populations
title_sort zoom in on antibody aggregates: a potential pitfall in the search of rare ev populations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923005/
https://www.ncbi.nlm.nih.gov/pubmed/33670624
http://dx.doi.org/10.3390/biomedicines9020206
work_keys_str_mv AT rasmussenrikkew zoominonantibodyaggregatesapotentialpitfallinthesearchofrareevpopulations
AT bothajaco zoominonantibodyaggregatesapotentialpitfallinthesearchofrareevpopulations
AT pripfrederik zoominonantibodyaggregatesapotentialpitfallinthesearchofrareevpopulations
AT sandenmathilde zoominonantibodyaggregatesapotentialpitfallinthesearchofrareevpopulations
AT nielsenmortenh zoominonantibodyaggregatesapotentialpitfallinthesearchofrareevpopulations
AT handbergaase zoominonantibodyaggregatesapotentialpitfallinthesearchofrareevpopulations